Astera Labs, Inc. Common Stock
ALABLast close · Oct 16, 2026285.82−16.16 (−5.35%)
Market cap$49.6B
9 firms' latest targets, last 90 days: median $425.00 ($275.00–$500.00), 49% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-08-17 | Northland Securities | $350.00 | ▲ 79% | +22% |
| 2026-08-05 | Roth Capital | $450.00 | ▲ 64% | +57% |
| 2026-08-05 | RBC Capital | $500.00 | ▲ 85% | +75% |
| 2026-08-05 | UBS | $425.00 | ▲ 6% | +49% |
| 2026-08-05 | Needham | $425.00 | ▲ 63% | +49% |
| 2026-08-05 | Jefferies | $450.00 | ▲ 67% | +57% |
| 2026-08-03 | Morgan Stanley | $335.00 | ▲ 40% | +17% |
| 2026-07-31 | Susquehanna | $275.00 | ▲ 20% | -4% |
| 2026-07-20 | Barclays | $325.00 | ▲ 63% | +14% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2024reported | $396.3M | +242% | -$0.64 | — | est. $383.2M+3% | est. $0.72 | 10 |
| 2025reported | $852.5M | +115% | $1.22 | — | est. $831.6M+3% | est. $1.78 | 15 |
| 2026 | $1.9B | +124% | $3.99 | +124% | $1.9B–$1.9B | $3.91–$4.09 | 16 |
| 2027 | $3.1B | +62% | $6.49 | +62% | $3.0B–$3.4B | $6.07–$7.29 | 18 |
| 2028 | $4.0B | +30% | $8.26 | +27% | $2.9B–$5.2B | $6.05–$11.04 | 19 |
| 2029 | $6.4B | +59% | $14.60 | +77% | $5.4B–$7.4B | $11.65–$17.78 | 9 |
| 2030 | $7.1B | +12% | $16.80 | +15% | $6.0B–$8.3B | $13.41–$20.47 | 15 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.